{"entity":{"type":"insider","cik":"0001378690","url":"/insider/0001378690","json_url":"/insider/0001378690.json","name":"Schroeder Theodore R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":9,"first":"2009-10-19","last":"2021-12-29","span_basis":"filed_date"},"name_variants":[{"name":"Schroeder Theodore R","source":"filing","n_filings":9,"first_seen":"2009-10-19","last_seen":"2021-12-29"}],"transactions":[{"id":5536726,"accession":"0001104659-21-154397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-154397","line_url":"/filing/0001104659-21-154397#line-1","is_derivative":false,"issuer_cik":"0001378690","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001378690","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.5732,"price_display":"0.57","price_state":"stated","total_value":57320.0,"total_display":"57,320.00","total_whole":"57,320","shares_owned_after":325879.0,"shares_owned_after_display":"325,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-29","scope":"insider"},{"id":4844318,"accession":"0001104659-21-116048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-116048","line_url":"/filing/0001104659-21-116048#line-1","is_derivative":false,"issuer_cik":"0001378690","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001378690","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":56500.0,"total_display":"56,500.00","total_whole":"56,500","shares_owned_after":226875.0,"shares_owned_after_display":"226,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-15","scope":"insider"},{"id":7995713,"accession":"0001104659-19-047723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047723","line_url":"/filing/0001104659-19-047723#line-1","is_derivative":false,"issuer_cik":"0001378690","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001378690","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":89500.0,"total_display":"89,500.00","total_whole":"89,500","shares_owned_after":117489.0,"shares_owned_after_display":"117,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-28","scope":"insider"},{"id":9046473,"accession":"0001209191-11-029100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-029100","line_url":"/filing/0001209191-11-029100#line-1","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":7.4766,"price_display":"7.48","price_state":"stated","total_value":119625.6,"total_display":"119,625.60","total_whole":"119,626","shares_owned_after":307500.0,"shares_owned_after_display":"307,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-17","filed_date":"2011-05-17","scope":"insider"},{"id":7775064,"accession":"0001209191-10-048672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-048672","line_url":"/filing/0001209191-10-048672#line-2","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9297.0,"shares_display":"9,297","price_per_share":8.3543,"price_display":"8.35","price_state":"stated","total_value":77669.9271,"total_display":"77,669.93","total_whole":"77,670","shares_owned_after":311000.0,"shares_owned_after_display":"311,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-01","filed_date":"2010-10-04","scope":"insider"},{"id":7775059,"accession":"0001209191-10-048672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-048672","line_url":"/filing/0001209191-10-048672#line-1","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40703.0,"shares_display":"40,703","price_per_share":8.3456,"price_display":"8.35","price_state":"stated","total_value":339690.9568,"total_display":"339,690.96","total_whole":"339,691","shares_owned_after":320297.0,"shares_owned_after_display":"320,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-30","filed_date":"2010-10-04","scope":"insider"},{"id":7207006,"accession":"0001209191-10-036630","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-036630","line_url":"/filing/0001209191-10-036630#line-2","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8979.0,"shares_display":"8,979","price_per_share":6.9497,"price_display":"6.95","price_state":"stated","total_value":62401.3563,"total_display":"62,401.36","total_whole":"62,401","shares_owned_after":361000.0,"shares_owned_after_display":"361,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-07-01","filed_date":"2010-07-01","scope":"insider"},{"id":7207004,"accession":"0001209191-10-036630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-036630","line_url":"/filing/0001209191-10-036630#line-1","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41021.0,"shares_display":"41,021","price_per_share":7.0025,"price_display":"7.00","price_state":"stated","total_value":287249.5525,"total_display":"287,249.55","total_whole":"287,250","shares_owned_after":369979.0,"shares_owned_after_display":"369,979","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-30","filed_date":"2010-07-01","scope":"insider"},{"id":7547274,"accession":"0001209191-10-019877","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-019877","line_url":"/filing/0001209191-10-019877#line-2","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21997.0,"shares_display":"21,997","price_per_share":9.0297,"price_display":"9.03","price_state":"stated","total_value":198626.3109,"total_display":"198,626.31","total_whole":"198,626","shares_owned_after":411000.0,"shares_owned_after_display":"411,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-01","filed_date":"2010-04-01","scope":"insider"},{"id":7547271,"accession":"0001209191-10-019877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-019877","line_url":"/filing/0001209191-10-019877#line-1","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28003.0,"shares_display":"28,003","price_per_share":9.2965,"price_display":"9.30","price_state":"stated","total_value":260329.8895,"total_display":"260,329.89","total_whole":"260,330","shares_owned_after":432997.0,"shares_owned_after_display":"432,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-31","filed_date":"2010-04-01","scope":"insider"},{"id":7769469,"accession":"0001209191-10-000257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-000257","line_url":"/filing/0001209191-10-000257#line-2","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10343.0,"shares_display":"10,343","price_per_share":9.8002,"price_display":"9.80","price_state":"stated","total_value":101363.4686,"total_display":"101,363.47","total_whole":"101,363","shares_owned_after":461000.0,"shares_owned_after_display":"461,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-04","filed_date":"2010-01-04","scope":"insider"},{"id":7769466,"accession":"0001209191-10-000257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-000257","line_url":"/filing/0001209191-10-000257#line-1","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19657.0,"shares_display":"19,657","price_per_share":9.7607,"price_display":"9.76","price_state":"stated","total_value":191866.0799,"total_display":"191,866.08","total_whole":"191,866","shares_owned_after":471343.0,"shares_owned_after_display":"471,343","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-31","filed_date":"2010-01-04","scope":"insider"},{"id":5845151,"accession":"0001209191-09-049071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-049071","line_url":"/filing/0001209191-09-049071#line-1","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001378690","owner_name":"Schroeder Theodore R","owner_display_name":"Schroeder Theodore R","owner_url":"/insider/0001378690","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":10.7188,"price_display":"10.72","price_state":"stated","total_value":214376.0,"total_display":"214,376.00","total_whole":"214,376","shares_owned_after":491000.0,"shares_owned_after_display":"491,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-10-16","filed_date":"2009-10-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641640","name":"Nabriva Therapeutics plc","url":"/issuer/0001641640","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2019-08-28","last_seen":"2021-12-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Director, Officer (President, CEO)","n_filings":6,"first_seen":"2009-10-19","last_seen":"2011-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378690","retrieved_at":"2026-08-22T12:00:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}